Unichem Labs to Challenge Rs 10.59 Lakh GST Demand After Partial Success in TRAN-1 Appeal

Written By :  Parthika Patel
Published On 2026-07-30 08:30 GMT   |   Update On 2026-07-30 08:30 GMT
Advertisement

Mumbai: Unichem Laboratories Limited has informed the stock exchanges that the Additional Commissioner, Central Goods and Services Tax (Appeals), Dehradun, has partially allowed the company's appeal relating to GSTR TRAN-1 credit.

The company stated that it had filed an appeal against an order passed by the Assistant Commissioner, Central Goods and Services Tax Division, Dehradun, which had disallowed TRAN-1 credit amounting to Rs. 73,02,757 under Section 140(3) of the CGST Act, 2017, along with proceedings under Sections 74 and 122 of the CGST Act.

Advertisement

Following the appeal, the Additional Commissioner, Central Goods and Services Tax (Appeals), Dehradun partially allowed the GSTR TRAN-1 credit. However, the appellate authority also passed an order raising a demand of Rs. 10,59,354, along with interest under Section 50 of the CGST Act.

According to the company, the order was received on July 28, 2026. The disclosure further noted that the matter relates to the partial disallowance of GSTR TRAN-1 credit.

Unichem Laboratories stated that the appellate order is not expected to have any material impact on the company's financial position, operations or other business activities. The company added that, based on legal advice, it will take appropriate steps, including filing an appeal against the order within the prescribed timelines.

The disclosure follows the company's earlier intimation dated January 27, 2025, regarding the matter.

Also Read: Unichem Labs: Dr Prakash Amrut Mody resigns as Managing Director, Pabitrakumar Kalipada Bhattacharyya takes charge

Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News